Lentiviral Gene Therapy for p47 AR-CGD
NCT05207657
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
5
Enrollment
OTHER
Sponsor class
Conditions
P47-Phox, Deficiency of
Interventions
DRUG:
Lentiviral vector transduced CD34+ cells
Sponsor
Great Ormond Street Hospital for Children NHS Foundation Trust